<DOC>
	<DOC>NCT01475981</DOC>
	<brief_summary>The purpose of this study was to determine the safety, tolerability and pharmacokinetics of ascending single oral doses of JTK-853 administered under fasted or fed conditions in healthy male subjects.</brief_summary>
	<brief_title>Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>1. Body mass index (BMI) of 1830 kg/m2 (inclusive) 2. Nonsmokers or subjects who have stopped smoking at least 6 months prior to the Screening Visit 1. History or presence of cardiac disease, including a family history of longQT syndrome or unexplained sudden death 2. Have used any prescription medication, herbal product, or overthecounter (OTC) medication (except acetaminophen), within 4 weeks prior to the Day before dosing</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>JTK-853</keyword>
	<keyword>single dose</keyword>
</DOC>